Losartan Potassium Tablet, Film Coated
Product Images NDC 64380-934

14 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 64380-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 01)

Image001 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 01)
Chemical structure of losartan potassium, showing the arrangement of atoms including chlorine, hydroxymethyl, aromatic rings, and potassium ion associated with the molecule.*
FDA Label Image

Image002 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 02)

Image002 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 02)
A line graph comparing the percentage of patients with the primary endpoint over study months for Atenolol (dotted line) and Losartan potassium (solid line). The graph shows a lower percentage for Losartan potassium, indicating an adjusted risk reduction of 13% with a significance of p=0.021 over approximately 66 months.*
FDA Label Image

Image003 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 03)

Image003 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 03)
A line graph comparing the percentage of patients with fatal/non-fatal stroke over 66 study months between Atenolol and Losartan potassium. The graph shows a lower percentage of stroke in patients treated with Losartan potassium compared to Atenolol, with an adjusted risk reduction of 25% (p=0.001). The x-axis represents study months, and the y-axis shows the percentage of patients with stroke.*
FDA Label Image

Image004 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 04)

Image004 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 04)
A forest plot comparing hazard ratios for primary composite events and stroke (fatal/non-fatal) events between Losartan Potassium and Atenolol across various patient subgroups, including age, gender, race, isolated systolic hypertension (ISH), diabetes status, and history of cardiovascular disease (CVD). The horizontal axis indicates hazard ratios ranging from 0.3 to 3, with markers showing event rates and confidence intervals, illustrating relative risk favoring Losartan Potassium or Atenolol.*
FDA Label Image

Image005 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 05)

Image005 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 05)
A line graph comparing the percentage of patients with an event over 48 months between Losartan potassium and placebo. The vertical axis represents % patients with event, and the horizontal axis represents months. Losartan potassium is shown with a solid line, placebo with a dotted line. Risk reduction is stated as 16.1% with p=0.022.*
FDA Label Image

25-30 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 06)

25-30 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 06)
Label for Losartan Potassium Tablets, USP 25 mg, film coated, manufactured by Strides Pharma Science Limited and distributed by Strides Pharma Inc. The package contains 30 film coated tablets. The label includes storage instructions, pharmacist dispensing information, a revision date of 07/2025, and barcodes.*
FDA Label Image

25-90 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 07)

25-90 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 07)
Label for Losartan Potassium 25 mg film-coated tablets, USP, by Strides Pharma Science Limited. The label shows the NDC 64380-933-05, 90 tablets per container, and storage instructions. Distributed by Strides Pharma Inc., Bridgewater, NJ. The label includes pharmacist instructions to dispense patient information separately and space for batch details.*
FDA Label Image

25-1000 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 08)

25-1000 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 08)
Label for Losartan Potassium Tablets USP 25 mg film-coated tablets, distributed by Strides Pharma Inc. The label includes storage instructions, dispensing advice for pharmacists, barcode, and batch space. Manufactured by Strides Pharma Science Limited in Tamil Nadu, India. Package contains 1000 film-coated tablets, Rx only.*
FDA Label Image

50-30 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 09)

50-30 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 09)
Packaging label for Losartan Potassium Tablets USP 50 mg, film coated, by Strides Pharma Science Limited. The label includes the NDC 64380-934-04, details on storage conditions, dispensing instructions, and manufacturing and distribution information. The package contains 30 film coated tablets, marked Rx Only, with a barcode visible.*
FDA Label Image

50-90 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 10)

50-90 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 10)
Label for Losartan Potassium Tablets USP 50 mg film-coated tablets by Strides Pharma Science Limited. The label indicates 90 tablets per container with directions to dispense patient information. Storage instructions specify 25°C with excursions. Includes manufacturer and distributor details with barcode and NDC 64380-934-05.*
FDA Label Image

50-1000 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 11)

50-1000 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 11)
Losartan Potassium 50 mg film-coated tablets label showing product name, strength, and dosage form. The label indicates the product contains 1000 tablets and is manufactured by Strides Pharma Science Limited in Tamil Nadu, India, and distributed by Strides Pharma Inc. Storage and dispensing instructions are provided. The label includes an NDC barcode and specifies Rx Only.*
FDA Label Image

100-30 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 12)

100-30 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 12)
Losartan Potassium 100 mg film-coated tablets label by Strides Pharma Science Limited. The label includes storage instructions, pharmacist information, and indicates a package size of 30 tablets. It also shows the NDC 64380-935-04, manufacturer address in Tamil Nadu, India, and distributor location in Bridgewater, NJ.*
FDA Label Image

100-90 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 13)

100-90 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 13)
Label for Losartan Potassium Tablets USP 100 mg, film coated, oral tablets manufactured by Strides Pharma Science Limited. The package contains 90 film coated tablets. Distributed by Strides Pharma Inc., Bridgewater, NJ. Storage instructions and pharmacist dispensing information are included. The label features barcodes and revision date 07/2025.*
FDA Label Image

100-1000 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 14)

100-1000 (Bf3fbbc7 Ee52 466f B5aa 3c6f8cebed32 14)
Label for Losartan Potassium Tablets, USP 100 mg, film-coated, oral use, distributed by Strides Pharma Inc. and manufactured by Strides Pharma Science Limited in India. Packaging contains 1000 tablets, with storage instructions and a barcode visible. The label includes a NDC code 64380-935-08 and directions for pharmacists to dispense patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.